O'Donnell Niall 4
4 · Reneo Pharmaceuticals, Inc. · Filed Jun 3, 2022
Insider Transaction Report
Form 4
O'Donnell Niall
Director
Transactions
- Award
Stock Option (right to buy)
2022-06-01+17,500→ 17,500 totalExercise: $2.09Exp: 2032-05-31→ Common Stock (17,500 underlying)
Footnotes (1)
- [F1]The shares subject to the option vest on the earlier of June 1, 2023 or the day prior to the date of the Issuer's 2023 annual meeting of stockholders, which date has not been set by the Issuer's Board of Directors.